Registration Now OPEN – BOPA Introduction to Oncology Course 2023 Leeds Cohort

Registration will initially open for delegates who wish to attend both study days.For delegates who wish to attend one of the two days only, registration will be available from Friday 13th January 2023.

The BOPA Introduction to Oncology Course 2023 Leeds Cohort
  • WHEN: Tuesday 7th March 2023 & Wednesday 8th March 2023
  • WHERE: The Bridge Conference Centre, Rider Street, Leeds LS9 7BQ (1.3 miles (10 min Taxi or 20min walk) from Leeds Train Station)
  • COST: Completely FREE for BOPA Paid Members (unfortunately travel expenses are not included)
  • CONTENT: Click here for the agenda
  • REGISTER: Via this link
  • PLACES: Only 50 places are available for each day, register early to avoid disappointment!
  • QUESTIONS – Please email:

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article